Metal complexes targeting the Translocator Protein 18 kDa (TSPO)

Nunzio Denora, Rosa Maria Iacobazzi, Giovanni Natile, Nicola Margiotta

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Since the discovery of antitumor activity of cisplatin in the late 60's, the development of metal-based drugs has had an enormous burst with the aim of to increase the anti-cancer activity, lower side effects and promote specific accumulation to the target cells or organs. Indeed, a new discipline, called medicinal inorganic chemistry, has born where metal ions play a fundamental role. This review provides a comprehensive overview of various metal complexes targeting the Translocator Protein (TSPO), an 18 kDa high affinity cholesterol- and drug-binding protein found mostly in the outer mitochondrial membrane and formerly known as peripheral-type benzodiazepine receptor. TSPO distribution in healthy tissues varies considerably; in contrast, aberrant expression of TSPO has been noted in several pathological specimens including neurodegenerative diseases and cancers. These findings suggest that TSPO-targeted therapy and imaging may have utility in the treatment and visualization of diseases expressing high density of TSPO. In this review, potential applications in cancer diagnosis and therapy will be discussed.

Original languageEnglish
Pages (from-to)1-18
Number of pages18
JournalCoordination Chemistry Reviews
Volume341
DOIs
Publication statusPublished - Jun 15 2017

Fingerprint

Coordination Complexes
Metal complexes
proteins
Proteins
metals
cancer
therapy
Neurodegenerative diseases
drugs
inorganic chemistry
Cholesterol
GABA-A Receptors
Pharmaceutical Preparations
cholesterol
Cisplatin
Metal ions
Carrier Proteins
organs
Visualization
Metals

Keywords

  • Diagnosis
  • Metal complexes
  • Peripheral Benzodiazepine Receptor
  • Therapy
  • Translocator Protein 18 kDa
  • TSPO

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Metal complexes targeting the Translocator Protein 18 kDa (TSPO). / Denora, Nunzio; Iacobazzi, Rosa Maria; Natile, Giovanni; Margiotta, Nicola.

In: Coordination Chemistry Reviews, Vol. 341, 15.06.2017, p. 1-18.

Research output: Contribution to journalReview article

Denora, Nunzio ; Iacobazzi, Rosa Maria ; Natile, Giovanni ; Margiotta, Nicola. / Metal complexes targeting the Translocator Protein 18 kDa (TSPO). In: Coordination Chemistry Reviews. 2017 ; Vol. 341. pp. 1-18.
@article{14aacbc8feef49f69b44e6c7936f4e4f,
title = "Metal complexes targeting the Translocator Protein 18 kDa (TSPO)",
abstract = "Since the discovery of antitumor activity of cisplatin in the late 60's, the development of metal-based drugs has had an enormous burst with the aim of to increase the anti-cancer activity, lower side effects and promote specific accumulation to the target cells or organs. Indeed, a new discipline, called medicinal inorganic chemistry, has born where metal ions play a fundamental role. This review provides a comprehensive overview of various metal complexes targeting the Translocator Protein (TSPO), an 18 kDa high affinity cholesterol- and drug-binding protein found mostly in the outer mitochondrial membrane and formerly known as peripheral-type benzodiazepine receptor. TSPO distribution in healthy tissues varies considerably; in contrast, aberrant expression of TSPO has been noted in several pathological specimens including neurodegenerative diseases and cancers. These findings suggest that TSPO-targeted therapy and imaging may have utility in the treatment and visualization of diseases expressing high density of TSPO. In this review, potential applications in cancer diagnosis and therapy will be discussed.",
keywords = "Diagnosis, Metal complexes, Peripheral Benzodiazepine Receptor, Therapy, Translocator Protein 18 kDa, TSPO",
author = "Nunzio Denora and Iacobazzi, {Rosa Maria} and Giovanni Natile and Nicola Margiotta",
year = "2017",
month = "6",
day = "15",
doi = "10.1016/j.ccr.2017.03.023",
language = "English",
volume = "341",
pages = "1--18",
journal = "Coordination Chemistry Reviews",
issn = "0010-8545",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Metal complexes targeting the Translocator Protein 18 kDa (TSPO)

AU - Denora, Nunzio

AU - Iacobazzi, Rosa Maria

AU - Natile, Giovanni

AU - Margiotta, Nicola

PY - 2017/6/15

Y1 - 2017/6/15

N2 - Since the discovery of antitumor activity of cisplatin in the late 60's, the development of metal-based drugs has had an enormous burst with the aim of to increase the anti-cancer activity, lower side effects and promote specific accumulation to the target cells or organs. Indeed, a new discipline, called medicinal inorganic chemistry, has born where metal ions play a fundamental role. This review provides a comprehensive overview of various metal complexes targeting the Translocator Protein (TSPO), an 18 kDa high affinity cholesterol- and drug-binding protein found mostly in the outer mitochondrial membrane and formerly known as peripheral-type benzodiazepine receptor. TSPO distribution in healthy tissues varies considerably; in contrast, aberrant expression of TSPO has been noted in several pathological specimens including neurodegenerative diseases and cancers. These findings suggest that TSPO-targeted therapy and imaging may have utility in the treatment and visualization of diseases expressing high density of TSPO. In this review, potential applications in cancer diagnosis and therapy will be discussed.

AB - Since the discovery of antitumor activity of cisplatin in the late 60's, the development of metal-based drugs has had an enormous burst with the aim of to increase the anti-cancer activity, lower side effects and promote specific accumulation to the target cells or organs. Indeed, a new discipline, called medicinal inorganic chemistry, has born where metal ions play a fundamental role. This review provides a comprehensive overview of various metal complexes targeting the Translocator Protein (TSPO), an 18 kDa high affinity cholesterol- and drug-binding protein found mostly in the outer mitochondrial membrane and formerly known as peripheral-type benzodiazepine receptor. TSPO distribution in healthy tissues varies considerably; in contrast, aberrant expression of TSPO has been noted in several pathological specimens including neurodegenerative diseases and cancers. These findings suggest that TSPO-targeted therapy and imaging may have utility in the treatment and visualization of diseases expressing high density of TSPO. In this review, potential applications in cancer diagnosis and therapy will be discussed.

KW - Diagnosis

KW - Metal complexes

KW - Peripheral Benzodiazepine Receptor

KW - Therapy

KW - Translocator Protein 18 kDa

KW - TSPO

UR - http://www.scopus.com/inward/record.url?scp=85017146989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017146989&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2017.03.023

DO - 10.1016/j.ccr.2017.03.023

M3 - Review article

VL - 341

SP - 1

EP - 18

JO - Coordination Chemistry Reviews

JF - Coordination Chemistry Reviews

SN - 0010-8545

ER -